Revive Therapeutics(RVVTF)
$0.01+0.00 (+7.69%)
RVVTF
Revive Therapeutics financials statements
$0.01
At close:+0.00 (+7.69%)
Revive Therapeutics (RVVTF) Financial Statements
58 Followers
Revive Therapeutics Financial Overview
Revive Therapeutics's market cap is currently C$6.24M. The company's EPS TTM is C$-0.00; its P/E ratio is -16.67; Revive Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -189.00 | C$ -248.00 | C$ -328.00 | C$ -434.00 | C$ -578.00 |
| Operating Income | C$ -1.05M | C$ -1.65M | C$ -3.29M | C$ -5.52M | C$ -17.83M |
| EBITDA | C$ -1.05M | C$ -11.01M | C$ -5.60M | C$ -5.52M | C$ -17.74M |
| Net Income | C$ -1.02M | C$ -11.01M | C$ -5.62M | C$ -6.32M | C$ -17.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 14.83K | C$ 24.56K | C$ 773.07K | C$ 2.09M | C$ 3.92M |
| Total Assets | C$ 283.38K | C$ 205.02K | C$ 10.64M | C$ 14.25M | C$ 17.07M |
| Total Debt | C$ 0.00 | C$ 66.87K | C$ 25.22K | C$ 219.69K | C$ 327.73K |
| Net Debt | C$ -14.83K | C$ 42.31K | C$ -797.85K | C$ -1.87M | C$ -3.59M |
| Total Liabilities | C$ 4.30M | C$ 3.66M | C$ 3.40M | C$ 3.60M | C$ 4.46M |
| Stockholders' Equity | C$ -4.02M | C$ -3.46M | C$ 7.23M | C$ 10.65M | C$ 12.60M |
| Cash Flow | |||||
| Free Cash Flow | C$ -158.53K | C$ -807.66K | C$ -3.29M | C$ -6.03M | C$ -13.06M |
| Operating Cash Flow | C$ -158.53K | C$ -807.66K | C$ -3.29M | C$ -6.03M | C$ -13.06M |
| Investing Cash Flow | C$ 0.00 | C$ -30.00K | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Financing Cash Flow | C$ 148.80K | C$ 39.15K | C$ 1.98M | C$ 4.20M | C$ 376.35K |
Currency in CAD
